Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
Why this paper is included
Supporting source evidence:
The baseline data laboratory indicatorsItemsResultsMale (%)60 (56.6)Age (years)62.1 ± 13.5Smoking (%)28 (26.4)Dialysis duration (months)58.8 ± 45.4DM (%)61 (57.5)LEAO (%)19 (17.9)CHD (%)56 (52.8)CAC (%)58 (54.7)CVC (%)68 (64.8) AVC (%)67 (63.8) MVC (%)26 (24.8) TVC (%)0 (0) AVC + MVC (%)25 (23.8)Combined tumor (%)13 (12.4)Kt/V1.40 ± 0.27GFR (ml/min/1.73 2 )4.71 ± 1.46Serum UA (µmol/L)454.1 ± 68.9Serum Ca (mmol/L)2.18 ± 0.15Serum P (mmol/L)1.89 ± 0.39Serum K (mmol/L)4.97 ± 0.51Serum Na (mmol/L)139.7 ± 2.7Serum Mg (mmol/L)1.11 ± 0.13Hb (g/L)117.4 ± 10.5PTH (ng/L)267.2 ± 154.7ALP (U/L)80.8 ± 32.8TP (g/L)65.5 ± 4.7Alb (g/L)40.1 ± 2.8Pre-Alb (mg/L)324.8 ± 60.7TC (mmol/L)3.70 ± 1.04TG (mmol/L)2.05 ± 1.15LDL-C (mmol/L)1.96 ± 0.85HDL-C (mmol/L)0.93 ± 0.27Drug Calcium carbonate (%)33 (31.1) Lanthanum carbonate (%)14 (13.2) Sevelamer (%)43 (40.6) Cinacalcet (%)20 (18.9) Calcitriol or Paricalcitol (%)50 (47.2)DM Diabetes mellitus, LEAO Lower extremity arterial occlusion, CHD Coronary heart disease, CAC Coronary artery calcification, GFR Glomerular filtration rate, UA Uric acid, Ca Calcium, P Phosphorus, K Potassium, Na Sodium, Mg Magnesium, Hb Hemoglobin, PTH Parathyroid hormone, ALP Alkaline phosphatase, TP Total protein, Alb Albumin, TC Total cholesterol, TG Triglycerides, LDL-C Low-density lipoprotein cholesterol, HDL-C High-density lipoprotein cholesterol
Source: General information. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Cross-sectional study.
Cross-sectional study
Examines a population at a particular point in time.
Meta-analysis unclear · Blinding unclear / not reported · Human research reported
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
A cross-sectional study was conducted in 105 maintenance hemodialysis patients with complete follow-up data from June 2020 to May 2021 in Beijing Tsinghua Changgung Hospital, Tsinghua University.
Source: Abstract.
According to their echocardiograms, patients were divided into a cardiac valve calcification group and a noncardiac valve calcification group, and the correlations between valve calcification and clinical data were analyzed.
Source: Abstract.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Serum magnesium level and cardiac valve calcification in hemodialysis patients
Cross-sectional study · BMC Cardiovascular Disorders · 2023
Original publication title
Serum magnesium level and cardiac valve calcification in hemodialysis patients
© The Author(s) 2023
Original publication · Publisher record · CC BY 4.0 · CC0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
Abstract: What background does the paper provide?
Cardiac valve calcification is closely related to cardiovascular disease. The aim of this study was to investigate the magnesium level and cardiac valve calcification in hemodialysis patients.
Source: IntroductionAbstract: What methods does the paper describe?
A cross-sectional study was conducted in 105 maintenance hemodialysis patients with complete follow-up data from June 2020 to May 2021 in Beijing Tsinghua Changgung Hospital, Tsinghua University. Baseline data, including sex, age, primary disease, liver and kidney function, electrolytes and parathyroid hormone, were recorded. According to their echocardiograms, patients were divided into a cardiac valve calcification group and a noncardiac valve calcification group, and the correlations between valve calcification and clinical data were analyzed.
Source: MethodsAbstract: Results
Of 105 patients under hemodialysis, 60 (56.6%) were male, with an average age of 62.1 ± 13.5 years and a mean dialysis duration of 58.8 ± 45.4 months. The majority of primary renal diseases were diabetic nephropathy (55, 51.9%). Approximately 64.8% of the 105 maintenance hemodialysis patients had cardiac valve calcification, and 35.2% were in the noncardiac valve calcification group. The independent t test and the chi-square test analysis showed that the cardiac valve calcification group had older age, higher smoking rate, diabetes mellitus, lower extremity arterial occlusion, coronary heart disease, and coronary artery calcification ratio but lower parathyroid hormone, serum calcium, serum magnesium, albumin, prealbumin, and high-density lipoprotein cholesterol levels (P < 0.05).
Logistic regression analysis showed that age, diabetes mellitus, coronary artery calcification, lower serum magnesium, lower serum calcium, and lower parathyroid hormone levels were associated with valve calcification.
Source: ResultsAbstract: Conclusion
The presence of cardiac valve calcification was associated with age, calcium, phosphorus and lower magnesium level. These factors we should pay more attention in clinical practice.
Source: ConclusionAuthors’ abstract
Introduction
Cardiac valve calcification is closely related to cardiovascular disease. The aim of this study was to investigate the magnesium level and cardiac valve calcification in hemodialysis patients.
Methods
A cross-sectional study was conducted in 105 maintenance hemodialysis patients with complete follow-up data from June 2020 to May 2021 in Beijing Tsinghua Changgung Hospital, Tsinghua University. Baseline data, including sex, age, primary disease, liver and kidney function, electrolytes and parathyroid hormone, were recorded. According to their echocardiograms, patients were divided into a cardiac valve calcification group and a noncardiac valve calcification group, and the correlations between valve calcification and clinical data were analyzed.
Results
Of 105 patients under hemodialysis, 60 (56.6%) were male, with an average age of 62.1 ± 13.5 years and a mean dialysis duration of 58.8 ± 45.4 months. The majority of primary renal diseases were diabetic nephropathy (55, 51.9%). Approximately 64.8% of the 105 maintenance hemodialysis patients had cardiac valve calcification, and 35.2% were in the noncardiac valve calcification group. The independent t test and the chi-square test analysis showed that the cardiac valve calcification group had older age, higher smoking rate, diabetes mellitus, lower extremity arterial occlusion, coronary heart disease, and coronary artery calcification ratio but lower parathyroid hormone, serum calcium, serum magnesium, albumin, prealbumin, and high-density lipoprotein cholesterol levels (P < 0.05).
Logistic regression analysis showed that age, diabetes mellitus, coronary artery calcification, lower serum magnesium, lower serum calcium, and lower parathyroid hormone levels were associated with valve calcification.
Conclusion
The presence of cardiac valve calcification was associated with age, calcium, phosphorus and lower magnesium level. These factors we should pay more attention in clinical practice.
Publication and source details
Original title: Serum magnesium level and cardiac valve calcification in hemodialysis patients
Shihming Tsai; Yuehong Li; Xianglan Wu
BMC Cardiovascular Disorders · 2023
© The Author(s) 2023https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.Capital’s Funds for Health Improvement and Research2022-3-2243Tsinghua Precision Medicine Research Program2022TS007Beijing Hospitals Authority Clinical medicine Development of special funding supportYGLX202332Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-11T14:16:35.871490+00:00
DOI: 10.1186/s12872-023-03662-5 · PMC10717005